2017 Annual Meeting of the Association for Research in Vision and Ophthalmology
Anti-VEGF in the Treatment of Retinal Disease:Bringing Long-term, Real-world Outcomes into Focus
By PETER J. KERTES, MD, CM, FRCSC
The Role of Nutritional Supplements in the Management of Age-related Macular Degeneration
By EFREM D. MANDELCORN, MD, FRCSC
ERRATUM
2016 Annual Meeting of the Association for Research in Vision and Ophthalmology
By DAVID ASSAAD, MD, FRCSC
American Academy of Ophthalmology Annual Meeting
Next Frontiers in the Management of Neovascular Age-related Macular Degeneration
Reported and discussed by: JASON NOBLE, MD, FRCSC
Analysis of the recent DCRC.net trial
Evaluating the Comparative Efficacy and Safety of Anti-VEGF Agents in Treating DME:
A Canadian Perspective on the Protocol T Trial
Reported and discussed by: DAVID ASSAAD, MD, FRCSC
2015 Canadian Retina Society Meeting
Management of Macular Holes in 2015
Reported and discussed by: DAVID R. CHOW, MD, FRCSC, MICHAEL KAPUSTA, MD, FRCSC,
and NETAN CHOUDHRY, MD, FRCSC, DABO
ASRS & AAO
Anti-VEGF in the Treatment of Retinal Disease: A Decade of Clinical Experience
Reported and discussed by: WAI-CHING LAM, MD, FRCSC and EMMANOUIL MAVRIKAKIS, MD, PhD
ARVO 2014
Contemporary Management of Retinal Disease: Focus on Individualized Treatment Approaches
Reported and discussed by: NUPURA K. BAKSHI, MD, FRCSC
ASRS
Management of Retinal Disease in the Era of Anti-VEGF Therapies
Reported and discussed by EFREM D. MANDELCORN, MD, FRCSC
Will Individualized Therapy Become Standard of Care for Age-related Macular Degeneration?
Reported and discussed by: PETER J. KERTES, MD, CM, FRCSC, and THOMAS G. SHEIDOW, MD, FRCSC, MMath
75th COS Annual Meeting
Canadian Ophthalmological Society (COS) Diabetic Retinopathy Guidelines: Implications for Daily Clinical Practice
Reported and discussed by: NUPURA BAKSHI, MD, FRCSC
2012 ARVO
New Insights into the Treatment of Wet Age-related Macular Degeneration in the Era of Anti-VEGF Therapies
Reported and discussed by: DAVID T. WONG, MD, FRCSC, and WAI CHING LAM, MD, FRCSC
Dry Eye: A Comprehensive Approach to Diagnosis and Management
Reported and discussed by: MATTHEW C. BUJAK, MD, FRCSC
Benefits and Risks of Inhibiting Vascular Endothelial Growth Factor (VEGF) at the Ocular Level:
From Bench to Bedside
Reported and discussed by: Subodh Verma, MD, PhD, FRCSC, FAHA; Alan R. Berger, BSc, MD, FRCSC; David R. Chow, MD, FRCSC
WOC and COS
Retina-related Highlights from WOC and COS
Reported and discussed by: WAI CHING LAM, MD, FRCSC, and PETER J. KERTES, MD, CM, FRCSC
Originally presented by: L. Aiello, MD; G. Lang, MD; P. Mitchell, MD; E. Tourville, MD; D. Wong, MD; B. Leonard, MD; G. Katz, MD; P. Kertes , MD; J . Kent , MD; T. Sheidow, MD; D. Chow, MD; P. Hooper, MD; E. Chew, MD